Granzyme B+ B cells detected by single-cell sequencing are associated with prognosis in patients with intrahepatic cholangiocarcinoma following liver transplantation
Abstract B cells possess anti-tumor functions mediated by granzyme B, in addition to their role in antigen presentation and antibody production. However, the variations in granzyme B+ B cells between tumor and non-tumor tissues have been largely unexplored. Therefore, we integrated 25 samples from the Gene Expression Omnibus database and analyzed the tumor immune microenvironment. The findings uncovered significant inter- and intra-tumoral heterogeneity. Notably, single-cell data showed higher proportions of granzyme B+ B cells in tumor samples compared to control samples, and these levels were positively associated with disease-free survival. The elevated levels of granzyme B+ B cells in tumor samples resulted from tumor cell chemotaxis through the MIF- (CD74 + CXCR4) signaling pathway. Furthermore, the anti-tumor function of granzyme B+ B cells in tumor samples was adversely affected, potentially providing an explanation for tumor progression. These findings regarding granzyme B+ B cells were further validated in an independent clinic cohort of 40 liver transplant recipients with intrahepatic cholangiocarcinoma. Our study unveils an interaction between granzyme B+ B cells and intrahepatic cholangiocarcinoma, opening up potential avenues for the development of novel therapeutic strategies against this disease..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:73 |
|---|---|
| Enthalten in: |
Cancer immunology immunotherapy - 73(2024), 3 vom: 22. Feb. |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Zhu, Ji-Qiao [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| BKL: | |
|---|---|
| Themen: |
Granzyme B+ B cells |
| Anmerkungen: |
© The Author(s) 2024 |
|---|
| doi: |
10.1007/s00262-023-03609-x |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
SPR055090079 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | SPR055090079 | ||
| 003 | DE-627 | ||
| 005 | 20240311094621.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240311s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s00262-023-03609-x |2 doi | |
| 035 | |a (DE-627)SPR055090079 | ||
| 035 | |a (SPR)s00262-023-03609-x-e | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q VZ |
| 082 | 0 | 4 | |a 610 |q VZ |
| 084 | |a 44.81 |2 bkl | ||
| 084 | |a 44.45 |2 bkl | ||
| 100 | 1 | |a Zhu, Ji-Qiao |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Granzyme B+ B cells detected by single-cell sequencing are associated with prognosis in patients with intrahepatic cholangiocarcinoma following liver transplantation |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a © The Author(s) 2024 | ||
| 520 | |a Abstract B cells possess anti-tumor functions mediated by granzyme B, in addition to their role in antigen presentation and antibody production. However, the variations in granzyme B+ B cells between tumor and non-tumor tissues have been largely unexplored. Therefore, we integrated 25 samples from the Gene Expression Omnibus database and analyzed the tumor immune microenvironment. The findings uncovered significant inter- and intra-tumoral heterogeneity. Notably, single-cell data showed higher proportions of granzyme B+ B cells in tumor samples compared to control samples, and these levels were positively associated with disease-free survival. The elevated levels of granzyme B+ B cells in tumor samples resulted from tumor cell chemotaxis through the MIF- (CD74 + CXCR4) signaling pathway. Furthermore, the anti-tumor function of granzyme B+ B cells in tumor samples was adversely affected, potentially providing an explanation for tumor progression. These findings regarding granzyme B+ B cells were further validated in an independent clinic cohort of 40 liver transplant recipients with intrahepatic cholangiocarcinoma. Our study unveils an interaction between granzyme B+ B cells and intrahepatic cholangiocarcinoma, opening up potential avenues for the development of novel therapeutic strategies against this disease. | ||
| 650 | 4 | |a Granzyme B+ B cells |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Intrahepatic cholangiocarcinoma |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Liver transplantation |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Single-cell sequencing |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Immune escape |7 (dpeaa)DE-He213 | |
| 700 | 1 | |a Zhu, Ying |4 aut | |
| 700 | 1 | |a Qi, Man |4 aut | |
| 700 | 1 | |a Zeng, Ye |4 aut | |
| 700 | 1 | |a Liu, Zhen-Jia |4 aut | |
| 700 | 1 | |a Ding, Cheng |4 aut | |
| 700 | 1 | |a Zhang, Tao |4 aut | |
| 700 | 1 | |a Li, Xian-Liang |4 aut | |
| 700 | 1 | |a Han, Dong-Dong |4 aut | |
| 700 | 1 | |a He, Qiang |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Cancer immunology immunotherapy |d Springer Berlin Heidelberg, 1976 |g 73(2024), 3 vom: 22. Feb. |w (DE-627)SPR003214370 |w (DE-600)1458489-X |x 1432-0851 |7 nnns |
| 773 | 1 | 8 | |g volume:73 |g year:2024 |g number:3 |g day:22 |g month:02 |
| 856 | 4 | 0 | |u https://dx.doi.org/10.1007/s00262-023-03609-x |z kostenfrei |3 Volltext |
| 912 | |a GBV_SPRINGER | ||
| 912 | |a SSG-OLC-PHA | ||
| 936 | b | k | |a 44.81 |q VZ |
| 936 | b | k | |a 44.45 |q VZ |
| 951 | |a AR | ||
| 952 | |d 73 |j 2024 |e 3 |b 22 |c 02 | ||